Literature DB >> 8537130

Characterization of the expressed CIITA allele in the class II MHC transcriptional mutant RJ2.2.5.

J A Brown1, X F He, S D Westerheide, J M Boss.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8537130     DOI: 10.1007/bf00186611

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


× No keyword cloud information.
  23 in total

1.  Purified X2 binding protein (X2BP) cooperatively binds the class II MHC X box region in the presence of purified RFX, the X box factor deficient in the bare lymphocyte syndrome.

Authors:  C S Moreno; P Emery; J E West; B Durand; W Reith; B Mach; J M Boss
Journal:  J Immunol       Date:  1995-11-01       Impact factor: 5.422

2.  Regulation of a transfected human class II major histocompatibility complex gene in human fibroblasts.

Authors:  J M Boss; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

3.  B-cell-specific and interferon-gamma-inducible regulation of the HLA-DR alpha gene.

Authors:  S Y Tsang; M Nakanishi; B M Peterlin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

4.  Protease treatment of nuclear extracts distinguishes between class II MHC X1 box DNA-binding proteins in wild-type and class II-deficient B cells.

Authors:  S L Hasegawa; J L Riley; J H Sloan; J M Boss
Journal:  J Immunol       Date:  1993-03-01       Impact factor: 5.422

5.  Cooperative binding between factors RFX and X2bp to the X and X2 boxes of MHC class II promoters.

Authors:  W Reith; M Kobr; P Emery; B Durand; C A Siegrist; B Mach
Journal:  J Biol Chem       Date:  1994-08-05       Impact factor: 5.157

6.  Detailed delineation of an interferon-gamma-responsive element important in human HLA-DRA gene expression in a glioblastoma multiform line.

Authors:  P V Basta; P A Sherman; J P Ting
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

7.  Class II MHC transcriptional mutants are defective in higher order complex formation.

Authors:  J L Riley; J M Boss
Journal:  J Immunol       Date:  1993-12-15       Impact factor: 5.422

8.  Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA.

Authors:  V Steimle; C A Siegrist; A Mottet; B Lisowska-Grospierre; B Mach
Journal:  Science       Date:  1994-07-01       Impact factor: 47.728

9.  Molecular analysis of G1B and G3A IFN gamma mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction.

Authors:  K C Chin; C Mao; C Skinner; J L Riley; K L Wright; C S Moreno; G R Stark; J M Boss; J P Ting
Journal:  Immunity       Date:  1994-11       Impact factor: 31.745

10.  A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome).

Authors:  V Steimle; B Durand; E Barras; M Zufferey; M R Hadam; B Mach; W Reith
Journal:  Genes Dev       Date:  1995-05-01       Impact factor: 11.361

View more
  13 in total

Review 1.  The bare lymphocyte syndrome: molecular clues to the transcriptional regulation of major histocompatibility complex class II genes.

Authors:  A DeSandro; U M Nagarajan; J M Boss
Journal:  Am J Hum Genet       Date:  1999-08       Impact factor: 11.025

2.  CIITA or RFX coding region loss of function mutations occur rarely in diffuse large B-cell lymphoma cases and cell lines with low levels of major histocompatibility complex class II expression.

Authors:  Lisa M Rimsza; Wing C Chan; Randy D Gascoyne; Elias Campo; Elaine S Jaffe; Louis M Staudt; Jan Delabie; Andreas Rosenwald; Shawn P Murphy
Journal:  Haematologica       Date:  2009-02-19       Impact factor: 9.941

3.  CIITA stimulation of transcription factor binding to major histocompatibility complex class II and associated promoters in vivo.

Authors:  K L Wright; K C Chin; M Linhoff; C Skinner; J A Brown; J M Boss; G R Stark; J P Ting
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

4.  Efficient repression of endogenous major histocompatibility complex class II expression through dominant negative CIITA mutants isolated by a functional selection strategy.

Authors:  S Bontron; C Ucla; B Mach; V Steimle
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

5.  PU.1 binds to a distal regulatory element that is necessary for B cell-specific expression of CIITA.

Authors:  Hyesuk Yoon; Jeremy M Boss
Journal:  J Immunol       Date:  2010-04-02       Impact factor: 5.422

6.  An isotype-specific activator of major histocompatibility complex (MHC) class II genes that is independent of class II transactivator.

Authors:  J Douhan; R Lieberson; J H Knoll; H Zhou; L H Glimcher
Journal:  J Exp Med       Date:  1997-06-02       Impact factor: 14.307

7.  The MHC class II transactivator (CIITA) requires conserved leucine charged domains for interactions with the conserved W box promoter element.

Authors:  J A Brown; E M Rogers; J M Boss
Journal:  Nucleic Acids Res       Date:  1998-09-15       Impact factor: 16.971

8.  Coordinated changes of histone modifications and HDAC mobilization regulate the induction of MHC class II genes by Trichostatin A.

Authors:  Manolis Gialitakis; Androniki Kretsovali; Charalampos Spilianakis; Lara Kravariti; Jörg Mages; Reinhard Hoffmann; Antonis K Hatzopoulos; Joseph Papamatheakis
Journal:  Nucleic Acids Res       Date:  2006-02-01       Impact factor: 16.971

9.  Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway.

Authors:  D M Miller; B M Rahill; J M Boss; M D Lairmore; J E Durbin; J W Waldman; D D Sedmak
Journal:  J Exp Med       Date:  1998-03-02       Impact factor: 14.307

10.  The insulator factor CTCF controls MHC class II gene expression and is required for the formation of long-distance chromatin interactions.

Authors:  Parimal Majumder; Jorge A Gomez; Brian P Chadwick; Jeremy M Boss
Journal:  J Exp Med       Date:  2008-03-17       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.